Clinical Trial Detail

NCT ID NCT04042506
Title SBRT as a Vaccination for Metastatic Melanoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

skin melanoma

ocular melanoma

melanoma

acral lentiginous melanoma

mucosal melanoma

Therapies

Nivolumab

Age Groups: adult senior

No variant requirements are available.